BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Issues related to device cybersecurity
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD SPANGLER | — |
Taxation/Internal Revenue Code TAX
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA JOHNSTON | — |
| DANNY LY | — |
| TODD SPANGLER | — |
| ELIZABETH WOODY | — |
Health Issues HCR
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combating Opioid Abuse for Care in Hospitals Act of 2018
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA JOHNSTON | — |
| DANNY LY | — |
| TODD SPANGLER | — |
| ELIZABETH WOODY | — |
Tariff (miscellaneous tariff bills) TAR
Administration tariffs
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD SPANGLER | — |
| ELIZABETH WOODY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.